Total Payments
$2,083
2024 Payments
$661.86
Companies
13
Transactions
66
Medicare Patients
1,072
Medicare Billing
$90,021
Payment Breakdown by Category
Food & Beverage$2,037 (97.7%)
Education$46.91 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,037 | 65 | 97.7% |
| Education | $46.91 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $578.67 | 28 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $399.99 | 10 | $0 (2024) |
| Alkermes, Inc. | $298.12 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $244.25 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $151.93 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $101.47 | 2 | $0 (2024) |
| Tris Pharma Inc | $80.58 | 2 | $0 (2023) |
| ITI, Inc. | $69.48 | 2 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $63.88 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $46.23 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $661.86 | 16 | Supernus Pharmaceuticals, Inc. ($341.18) |
| 2023 | $554.11 | 16 | Teva Pharmaceuticals USA, Inc. ($151.93) |
| 2022 | $216.19 | 3 | Alkermes, Inc. ($77.11) |
| 2021 | $651.27 | 31 | AbbVie Inc. ($260.04) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $84.27 | General |
| Category: Neuropsychiatry | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $109.91 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/25/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $61.46 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/12/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $120.36 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $60.18 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $51.15 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/06/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: PSYCHOLOGY | ||||||
| 11/14/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: PSYCHOLOGY | ||||||
| 11/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Central Nervous System | ||||||
| 10/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $64.87 | General |
| Category: ADHD | ||||||
| 09/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $106.97 | General |
| Category: Neurology | ||||||
| 08/10/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: PSYCHOLOGY | ||||||
| 08/03/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 121 | 300 | $36,565 | $13,467 |
| 2022 | 3 | 110 | 234 | $29,555 | $10,977 |
| 2021 | 5 | 358 | 564 | $49,744 | $31,092 |
| 2020 | 5 | 483 | 794 | $62,715 | $34,485 |
Total Patients
1,072
Total Services
1,892
Medicare Billing
$90,021
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 156 | $15,660 | $5,556 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 95 | $13,255 | $5,282 | 39.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 11 | 21 | $3,465 | $1,198 | 34.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 11 | 11 | $3,080 | $1,174 | 38.1% |
| 90853 | Group psychotherapy | Facility | 2023 | 13 | 17 | $1,105 | $256.36 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 135 | $12,825 | $4,689 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 78 | $10,850 | $4,367 | 40.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 21 | 21 | $5,880 | $1,922 | 32.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 146 | 293 | $22,200 | $11,819 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 148 | $14,403 | $10,898 | 75.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 51 | 51 | $7,216 | $4,868 | 67.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 59 | $4,700 | $2,720 | 57.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 13 | $1,225 | $786.94 | 64.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 216 | 478 | $35,975 | $21,148 | 58.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 173 | 222 | $16,601 | $7,569 | 45.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 53 | 53 | $7,339 | $4,494 | 61.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $1,160 | $697.64 | 60.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 24 | 24 | $1,640 | $576.44 | 35.1% |
About Diane Boyd, APN
Diane Boyd, APN is a Psychiatric/Mental Health healthcare provider based in Pine Bluff, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225261282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Diane Boyd, APN has received a total of $2,083 in payments from pharmaceutical and medical device companies, with $661.86 received in 2024. These payments were reported across 66 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,037).
As a Medicare-enrolled provider, Boyd has provided services to 1,072 Medicare beneficiaries, totaling 1,892 services with total Medicare billing of $90,021. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Pine Bluff, AR
- Active Since 08/25/2009
- Last Updated 03/25/2010
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1225261282
Products in Payments
- VRAYLAR (Drug) $578.67
- Qelbree (Drug) $341.18
- LYBALVI (Drug) $195.83
- REXULTI (Drug) $195.52
- UZEDY (Drug) $106.97
- ARISTADA (Drug) $102.29
- INGREZZA (Drug) $101.47
- Dyanavel XR (Drug) $80.58
- CAPLYTA (Drug) $69.48
- ABILIFY MAINTENA (Drug) $65.88
- QUVIVIQ (Drug) $63.88
- QELBREE (Drug) $58.81
- INVEGA TRINZA (Drug) $32.18
- Austedo XR (Drug) $24.70
- AUSTEDO (Drug) $20.26
- KAPSPARGO (Drug) $16.42
- LOREEV XR (Drug) $15.26
- INVEGA SUSTENNA (Drug) $14.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Pine Bluff
Mallori Levengood
Psychiatric/Mental Health — Payments: $10,744
Psychiatric/Mental Health $10,744
Dr. Ashley James, Dnp, Aprn, DNP, APRN
Psychiatric/Mental Health — Payments: $1,825
Psychiatric/Mental Health $1,825
Devon Deden, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $211.83
Psychiatric/Mental Health $211.83
Toni Thomas, Lpn, LPN
Psychiatric/Mental Health — Payments: $79.80
Psychiatric/Mental Health $79.80
Michele Reynolds, Anp, ANP
Psychiatric/Mental Health — Payments: $23.22
Psychiatric/Mental Health $23.22
Ms. Sherry Raber, Rn, RN
Psychiatric/Mental Health
Psychiatric/Mental Health